Literature DB >> 2468336

Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis.

M Rooney1, A Whelan, C Feighery, B Bresnihan.   

Abstract

Multiple samples of synovial membrane were obtained by needle biopsy from 24 patients with rheumatoid arthritis (RA) before, and 1 year after, standard antirheumatic drug therapy was given. Changes in the immunohistologic features of the synovial membrane (read blindly) were compared with the clinical course of RA in each patient. A composite clinical index of disease activity (IDA) and spontaneous in vitro synthesis of IgM rheumatoid factor (IgM-RF) by blood mononuclear cells were also measured before and after treatment. In 16 patients (group A), the IDA indicated 26-69% improvement, and the values for spontaneous IgM-RF decreased substantially. In 8 patients (group B), the IDA indicated deterioration or no improvement, and the values for spontaneous IgM-RF were unchanged. In group A patients, the intensity of the T cell infiltrate decreased from a mean score of 1.3 to a mean score of 0.8 (P = 0.025). The ratio of T helper cells to T suppressor/cytotoxic cells was greater than or equal to 2:1 in 90% of group A patients before treatment, compared with 20% of these patients after treatment (P = 0.016), and the number of biopsy samples that contained identifiable B cells decreased from 36% before treatment to 7% after treatment. In group B patients, there were no changes in the intensity of T cell infiltration, the ratio of T helper cells to T suppressor/cytotoxic cells, or the number of biopsy samples with identifiable B cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468336     DOI: 10.1002/anr.1780320402

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

Review 1.  Synovial biopsy in arthritis research: five years of concerted European collaboration.

Authors:  B Bresnihan; P P Tak; P Emery; L Klareskog; F Breedveld
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

Review 2.  Standardisation of synovial tissue infiltrate analysis: how far have we come? How much further do we need to go?

Authors:  M D Smith; D Baeten; A-K Ulfgren; I B McInnes; O Fitzgerald; B Bresnihan; P P Tak; D Veale
Journal:  Ann Rheum Dis       Date:  2005-06-23       Impact factor: 19.103

3.  [Synovialitis score: histopathological grading system for chronic rheumatic and non-rheumatic synovialitis].

Authors:  V Krenn; L Morawietz; G-R Burmester; T Häupl
Journal:  Z Rheumatol       Date:  2005-06       Impact factor: 1.372

4.  Immunohistological analysis of the synovial membrane: search for predictors of the clinical course in rheumatoid arthritis.

Authors:  M Soden; M Rooney; A Whelan; C Feighery; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

5.  [Low-grade-/high-grade-synovitis: synovitis-score as a gold standard?].

Authors:  V Krenn; L Morawietz; B König; M Otto; J Kriegsmann; A Köpenik; T Böhme; T Häupl
Journal:  Orthopade       Date:  2006-08       Impact factor: 1.087

Review 6.  Liquid biopsies to guide therapeutic decisions in rheumatoid arthritis.

Authors:  Roxana Coras; Rekha Narasimhan; Monica Guma
Journal:  Transl Res       Date:  2018-07-19       Impact factor: 7.012

Review 7.  Synovial tissue research: a state-of-the-art review.

Authors:  Carl Orr; Elsa Vieira-Sousa; David L Boyle; Maya H Buch; Christopher D Buckley; Juan D Cañete; Anca I Catrina; Ernest H S Choy; Paul Emery; Ursula Fearon; Andrew Filer; Danielle Gerlag; Frances Humby; John D Isaacs; Søren A Just; Bernard R Lauwerys; Benoit Le Goff; Antonio Manzo; Trudy McGarry; Iain B McInnes; Aurélie Najm; Constantino Pitzalis; Arthur Pratt; Malcolm Smith; Paul P Tak; Rogier Thurlings; João E Fonseca; Douglas J Veale; Sander W Tas
Journal:  Nat Rev Rheumatol       Date:  2017-07-13       Impact factor: 20.543

8.  Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos.

Authors:  M L Handel; C K Watts; A deFazio; R O Day; R L Sutherland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.

Authors:  A Crilly; R Madhok; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

10.  Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.

Authors:  T Rooney; E Murphy; M Benito; P Roux-Lombard; O FitzGerald; J-M Dayer; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.